De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

BioNeutra Global Dividend

Dividend criteriumcontroles 0/6

BioNeutra Global heeft geen dividenduitkeringen gedaan.

Belangrijke informatie

n/a

Dividendrendement

n/a

Uitbetalingsratio

Gemiddelde opbrengst industrie	3.1%
Volgende betaaldatum dividend	n/a
Ex-dividenddatum	n/a
Dividend per aandeel	n/a
Winst per aandeel	-CA$0.033
Dividendrendementsvoorspelling	n/a

Recente dividendupdates

Geen updates

Recent updates

Calculating The Fair Value Of BioNeutra Global Corporation (CVE:BGA)

Dec 30

A Look At The Fair Value Of BioNeutra Global Corporation (CVE:BGA)

Aug 24

We Discuss Why BioNeutra Global Corporation's (CVE:BGA) CEO Compensation May Be Closely Reviewed

Sep 15

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: Er zijn onvoldoende gegevens om te bepalen of het dividend per aandeel van BGA in het verleden stabiel is geweest.

Groeiend dividend: Er zijn onvoldoende gegevens om te bepalen of de dividendbetalingen van BGA zijn gestegen.

Dividendrendement versus markt

BioNeutra Global Dividendrendement versus markt

Hoe verhoudt BGA dividendrendement zich tot de markt?
Segment	Dividendrendement
Bedrijf (BGA)	n/a
Markt onderkant 25% (CA)	1.7%
Markt Top 25% (CA)	5.9%
Gemiddelde industrie (Food)	3.1%
Analist prognose (BGA) (tot 3 jaar)	n/a

Opmerkelijk dividend: Het dividendrendement van BGA kan niet worden vergeleken met dat van de onderste 25% van de dividendbetalers, aangezien het bedrijf geen recente uitbetalingen heeft gerapporteerd.

Hoog dividend: Het dividendrendement van BGA kan niet worden vergeleken met dat van de top 25% van de dividendbetalers, aangezien het bedrijf geen recente uitbetalingen heeft gerapporteerd.

Winstuitkering aan aandeelhouders

Verdiendekking: Er zijn onvoldoende gegevens om de payout ratio BGA te berekenen en vast te stellen of de dividendbetalingen worden gedekt door de winst.

Contante uitbetaling aan aandeelhouders

Kasstroomdekking: De duurzaamheid van het dividend kan niet worden berekend, omdat BGA geen uitbetalingen heeft gerapporteerd.

BioNeutra Global Dividend

Dividend criteriumcontroles 0/6

Belangrijke informatie

Recente dividendupdates

Recent updates

High number of new directors

Second quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.027 loss in 2Q 2023)

BioNeutra Global Corporation, Annual General Meeting, Sep 09, 2024

First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.02 loss in 1Q 2023)

Less than half of directors are independent

Full year 2023 earnings released: CA$0.05 loss per share (vs CA$0.063 loss in FY 2022)

BioNeutra Global Corporation Appoints Stephen Jakeway as Chief Operating Officer

Less than half of directors are independent

Third quarter 2023 earnings released: CA$0.03 loss per share (vs CA$0.027 loss in 3Q 2022)

Less than half of directors are independent

BioNeutra Global Corporation Appoints Mr. Bill Smith to the Board of Directors

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

BioNeutra Global Corporation Announces Executive Changes

Less than half of directors are independent

Full year 2022 earnings released: CA$0.06 loss per share (vs CA$0.061 loss in FY 2021)

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Calculating The Fair Value Of BioNeutra Global Corporation (CVE:BGA)

Less than half of directors are independent

Third quarter 2022 earnings released: CA$0.03 loss per share (vs CA$0.016 loss in 3Q 2021)

Less than half of directors are independent

Now 40% undervalued

A Look At The Fair Value Of BioNeutra Global Corporation (CVE:BGA)

Second quarter 2022 earnings released: CA$0.01 loss per share (vs CA$0.001 loss in 2Q 2021)

Less than half of directors are independent

BioNeutra Global Corporation Appoints Ross Montagano as Chief Operating Officer

Less than half of directors are independent

First quarter 2022 earnings released

BioNeutra Global Corporation, Annual General Meeting, Jul 08, 2022

Full year 2021 earnings released: CA$0.06 loss per share (vs CA$0.08 loss in FY 2020)

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Less than half of directors are independent

We Discuss Why BioNeutra Global Corporation's (CVE:BGA) CEO Compensation May Be Closely Reviewed

Is BioNeutra Global (CVE:BGA) Using Too Much Debt?

First quarter 2021 earnings released: CA$0.03 loss per share (vs CA$0.024 loss in 1Q 2020)

Chairman Peter Watson has left the company

Is BioNeutra Global (CVE:BGA) Weighed On By Its Debt Load?

New 90-day high: CA$0.30

Does BioNeutra Global (CVE:BGA) Have A Healthy Balance Sheet?

Third quarter 2020 earnings released: CA$0.001 loss per share

Bioneutra Global Corporation Announces Executive Appointments

Bioneutra Global Corporation Appoints Bill Smith as Senior Vice President

Stabiliteit en groei van betalingen

Dividendrendement versus markt

Winstuitkering aan aandeelhouders

Contante uitbetaling aan aandeelhouders

Ontdek bedrijven met een sterk dividend